Judge accepts Paxil deal

Share this article:
An Illinois judge approved a $64-million class-action deal involving anti-depressant Paxil. The agreement, under which plaintiffs can get full refunds for their Paxil purchases, settles claims GlaxoSmithKline misled consumers by promoting the drug to children. Parties in the suit originally made the arrangement last November, contingent on a hearing to determine whether the settlement was fair and whether plaintiff’s attorneys were entitled to the $16 million settlement fee they requested. Last year the FDA issued warnings against use of Paxil in children after studies found the drug increased suicidal tendencies while having questionable effects on depression.
Share this article:

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?